Status: Not yet recruiting
An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy
The goals of this interventional study are (1) to evaluate the safety and tolerability of multiple doses of PST-611 in men and women over the age of 65 with geographic atrophy secondary to age-related macular degeneration and (2) to assess efficacy of multiple doses of PST-611 by assessing retinal morphology and visual function changes over time. Participants will: * receive one dose every 20 weeks, for a total of 3 doses. * will be followed up for a total of 52 weeks following the first PST-611 dose.
Participants needed: 24
Trial details
Phase: Phase 2Age: 65+Biological sex: AllType: InterventionalSponsor: EyevensysUpdated: Jul 16, 2026Locations: 3
Eligibility criteria
Subjects must give written informed consent, be able to make the required trial... [+7]
Both eyes (OU): any active intraocular or periocular infection or inflammation (... [+12]